#usp 1207

USP <1207> Vacuum Decay Leak Tester from Saicheng Instrument, high-sensitivity detection delivers repeatable and consistent results, enabling pharmaceutical manufacturers to achieve high-quality container seal integrity and ensure sterility throughout the drug's lifecycle.

Container Closure Integrity (CCI) testing ensures that pharmaceutical packaging systems maintain sterility and product quality throughout their shelf life. USP <1207> provides a detailed framework for evaluating the integrity of container closure systems, offering guidance on testing methodologies, validation, and regulatory expectations. By following these guidelines, manufacturers can verify the reliability of their packaging and address potential risks, such as contamination or leakage. USP <1207> emphasizes the use of advanced, reliable, and non-destructive testing methods to support consistent results. This approach strengthens compliance with regulatory requirements while helping ensure safe and effective pharmaceutical products reach patients.

Conducting feasibility studies for package testing is a critical step in validating the effectiveness of packaging systems. These studies assess whether the chosen testing methods and equipment can accurately and reliably detect potential issues, such as leaks, contamination, or physical damage. Check out our video to learn about the role of feasibility studies in testing package quality.